Find Entecavir manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as:
Molecular Formula
C12H15N5O3
Molecular Weight
277.28  g/mol
InChI Key
QDGZDCVAUDNJFG-FXQIFTODSA-N

Entecavir
1 2D Structure

Entecavir

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3H-purin-6-one
2.1.2 InChI
InChI=1S/C12H15N5O3/c1-5-6(3-18)8(19)2-7(5)17-4-14-9-10(17)15-12(13)16-11(9)20/h4,6-8,18-19H,1-3H2,(H3,13,15,16,20)/t6-,7-,8-/m0/s1
2.1.3 InChI Key
QDGZDCVAUDNJFG-FXQIFTODSA-N
2.1.4 Canonical SMILES
C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N
2.1.5 Isomeric SMILES
C=C1[C@H](C[C@@H]([C@H]1CO)O)N2C=NC3=C2NC(=NC3=O)N
2.2 Create Date
2005-08-01
3 Chemical and Physical Properties
Molecular Weight 277.28 g/mol
Molecular Formula C12H15N5O3
XLogP3-0.8
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count4
Rotatable Bond Count2
Exact Mass277.11748936 g/mol
Monoisotopic Mass277.11748936 g/mol
Topological Polar Surface Area126 A^2
Heavy Atom Count20
Formal Charge0
Complexity480
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 4  
Drug NameBaraclude
PubMed HealthEntecavir (By mouth)
Drug ClassesAntiviral
Drug LabelBARACLUDE is the tradename for entecavir, a guanosine nucleoside analogue with selective activity against HBV. The chemical name for entecavir is 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one,...
Active IngredientEntecavir
Dosage FormTablet; Solution
RouteOral
Strength0.5mg; 0.05mg/ml; 1mg
Market StatusPrescription
CompanyBristol Myers Squibb

2 of 4  
Drug NameEntecavir
PubMed HealthEntecavir (By mouth)
Drug ClassesAntiviral
Drug LabelBARACLUDE is the tradename for entecavir, a guanosine nucleoside analogue with selective activity against HBV. The chemical name for entecavir is 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one,...
Active IngredientEntecavir
Dosage FormTablet
RouteOral
Strength0.5mg; 1mg
Market StatusPrescription
CompanyTeva Pharms Usa

3 of 4  
Drug NameBaraclude
PubMed HealthEntecavir (By mouth)
Drug ClassesAntiviral
Drug LabelBARACLUDE is the tradename for entecavir, a guanosine nucleoside analogue with selective activity against HBV. The chemical name for entecavir is 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one,...
Active IngredientEntecavir
Dosage FormTablet; Solution
RouteOral
Strength0.5mg; 0.05mg/ml; 1mg
Market StatusPrescription
CompanyBristol Myers Squibb

4 of 4  
Drug NameEntecavir
PubMed HealthEntecavir (By mouth)
Drug ClassesAntiviral
Drug LabelBARACLUDE is the tradename for entecavir, a guanosine nucleoside analogue with selective activity against HBV. The chemical name for entecavir is 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one,...
Active IngredientEntecavir
Dosage FormTablet
RouteOral
Strength0.5mg; 1mg
Market StatusPrescription
CompanyTeva Pharms Usa

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - TABLET;ORAL - 0.5MG

USFDA APPLICATION NUMBER - 21797

read-more

DOSAGE - TABLET;ORAL - 1MG

USFDA APPLICATION NUMBER - 21797

read-more

DOSAGE - SOLUTION;ORAL - 0.05MG/ML

USFDA APPLICATION NUMBER - 21798

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Direct Compression

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Granulation

read-more
read-more

Solubilizers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Taste Masking

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Parenteral

read-more
read-more

Topical

read-more
read-more

Lubricants & Glidants

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

API Stability Enhancers

read-more
read-more

Emulsifying Agents

read-more
read-more

Empty Capsules

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Vegetarian Capsules

read-more
read-more

Rheology Modifiers

read-more
read-more

Coloring Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ANALYTICAL

Upload your methods for free, ask us

ABOUT THIS PAGE

Looking for / Entecavir API manufacturers, exporters & distributors?

Entecavir manufacturers, exporters & distributors 1

35

PharmaCompass offers a list of Entecavir API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Entecavir manufacturer or Entecavir supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Entecavir manufacturer or Entecavir supplier.

PharmaCompass also assists you with knowing the Entecavir API Price utilized in the formulation of products. Entecavir API Price is not always fixed or binding as the Entecavir Price is obtained through a variety of data sources. The Entecavir Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Entecavir

Barcavir Manufacturers

A Barcavir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Barcavir, including repackagers and relabelers. The FDA regulates Barcavir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Barcavir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Barcavir manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Barcavir Suppliers

A Barcavir supplier is an individual or a company that provides Barcavir active pharmaceutical ingredient (API) or Barcavir finished formulations upon request. The Barcavir suppliers may include Barcavir API manufacturers, exporters, distributors and traders.

click here to find a list of Barcavir suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Barcavir USDMF

A Barcavir DMF (Drug Master File) is a document detailing the whole manufacturing process of Barcavir active pharmaceutical ingredient (API) in detail. Different forms of Barcavir DMFs exist exist since differing nations have different regulations, such as Barcavir USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Barcavir DMF submitted to regulatory agencies in the US is known as a USDMF. Barcavir USDMF includes data on Barcavir's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Barcavir USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Barcavir suppliers with USDMF on PharmaCompass.

Barcavir JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Barcavir Drug Master File in Japan (Barcavir JDMF) empowers Barcavir API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Barcavir JDMF during the approval evaluation for pharmaceutical products. At the time of Barcavir JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Barcavir suppliers with JDMF on PharmaCompass.

Barcavir KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Barcavir Drug Master File in Korea (Barcavir KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Barcavir. The MFDS reviews the Barcavir KDMF as part of the drug registration process and uses the information provided in the Barcavir KDMF to evaluate the safety and efficacy of the drug.

After submitting a Barcavir KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Barcavir API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Barcavir suppliers with KDMF on PharmaCompass.

Barcavir CEP

A Barcavir CEP of the European Pharmacopoeia monograph is often referred to as a Barcavir Certificate of Suitability (COS). The purpose of a Barcavir CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Barcavir EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Barcavir to their clients by showing that a Barcavir CEP has been issued for it. The manufacturer submits a Barcavir CEP (COS) as part of the market authorization procedure, and it takes on the role of a Barcavir CEP holder for the record. Additionally, the data presented in the Barcavir CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Barcavir DMF.

A Barcavir CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Barcavir CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Barcavir suppliers with CEP (COS) on PharmaCompass.

Barcavir WC

A Barcavir written confirmation (Barcavir WC) is an official document issued by a regulatory agency to a Barcavir manufacturer, verifying that the manufacturing facility of a Barcavir active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Barcavir APIs or Barcavir finished pharmaceutical products to another nation, regulatory agencies frequently require a Barcavir WC (written confirmation) as part of the regulatory process.

click here to find a list of Barcavir suppliers with Written Confirmation (WC) on PharmaCompass.

Barcavir NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Barcavir as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Barcavir API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Barcavir as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Barcavir and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Barcavir NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Barcavir suppliers with NDC on PharmaCompass.

Barcavir GMP

Barcavir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Barcavir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Barcavir GMP manufacturer or Barcavir GMP API supplier for your needs.

Barcavir CoA

A Barcavir CoA (Certificate of Analysis) is a formal document that attests to Barcavir's compliance with Barcavir specifications and serves as a tool for batch-level quality control.

Barcavir CoA mostly includes findings from lab analyses of a specific batch. For each Barcavir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Barcavir may be tested according to a variety of international standards, such as European Pharmacopoeia (Barcavir EP), Barcavir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Barcavir USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty